Retrobulbar irradiation for thyroid eye disease

Current evidence on the safety and efficacy of retrobulbar irradiation for thyroid eye disease appears adequate to support the use of this procedure in patients for whom other treatments are inadequate or associated with significant side effects. Normal arrangements should be in place for consent, audit and clinical governance.

Patient selection should be made with the involvement of a multidisciplinary team that includes an ophthalmologist, a clinical oncologist and an endocrinologist.